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Abstract 
The friction behaviour of new chitosan derivative coatings obtained by chemical modification of 
chitosan with fatty acids (linoleic and dilinoleic acid) has been investigated in order to explore their 
potential as endovascular catheter coatings and to benchmark them against commercially available 
coatings used in endovascular catheter applications. An in vitro tribological system was developed 
that was intended to represent to a limited extent the in vivo tribological conditions of a typical 
endovascular catheterization procedure. Continuous reciprocating sliding tests were carried out with 
uncoated and coated polymer specimens. The results showed that all of the coatings tested decreased 
the coefficient of friction compared to the uncoated polymer. Compared to a neat chitosan coating, 
the chitosan derivative coatings showed a clear reduction in the coefficient of friction to levels similar 
to those of the commercially-available coatings. A comparison between the friction results and 
contact angle measurements carried out on the coatings indicated that a range of contact angle values 
exists for which the friction coefficient is at a minimum. The reason for this is unclear and further 
studies are required in order to confirm and investigate the trend, especially within the context of 
hydrophilic lubricious coating development. 
 




Rapid progress and increasing needs in the biomedical field have contributed to the extensive 
development of polymeric coatings. Many of the improvements of currently used devices and new 
solutions have been led by the variety and tailor-made properties of polymer coatings [1–5]. The 
application of hydrophilic-type coatings can provide advantages such as good wetting, inducement of 
capillary flow, good biocompatibility, low protein adsorption, and in contact with blood, reduction of 
the risk of thrombogenesis. In endovascular catheterisation procedures, friction against the luminal 
surface of a blood vessel along which the catheter passes is integral to the insertion, manipulation and 
removal of the catheter by the operator. A hydrophilic coating on the catheter can replace or 
supplement the lubricating action of the endothelial surface layer[6], facilitating catheterisation[7]. 
Existing hydrophilic coatings are formed by polymers with functional groups able to absorb water 
molecules, such as amino, hydroxyl or carboxyl groups.  For this reason the most commonly used 
polymers are acrylic polymers, polyvinyl alcohol (PVA), polyvinyl pyrrolidone (PVP), polyethylene 
glycols (PEG)s, some natural polymers such as polysaccharides, and various derivatives and their 
copolymers [8]. The primary focus of commercially available hydrophilic coatings for endovascular 
catheters is on improving the lubricity, maintaining a low and stable friction for the relatively short 
distance that the catheter slides against the vessel wall during the catheterisation procedure. This 
distance is associated with inserting, positioning, and removing the catheter after the treatment has 
taken place. For such applications, provided the friction does not increase during sliding, the coating 
wear behaviour is of minor importance since the catheters are single-use devices, discarded after use.  
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However, while these coatings have proven effective at reducing the incidence of spasm and 
improving patient comfort, the use of hydrophilic sheaths does not appear to prevent the reduction in 
flow mediated dilation, an index of endothelial dysfunction[9], and did not markedly influence the 
incidence of radial occlusion[10,11]. Further, the use of certain hydrophilic coatings (for example, 
those manufactured by Cook[12,13]) has been associated with the formation of sterile granulomas 
and abscesses[14–18]. Clearly, there is substantial room for improvement in the field of lubricious 
coatings for endovascular catheter use and, in particular, biodegradability would be a marked 
advantage. 
 
Chitosan is a natural hydrophilic polysaccharide, which can absorb water, due to the presence of 
amino groups in the structure, despite being insoluble in water. It is also  non-toxic, biocompatible, 
and, importantly, biodegradable, in addition to possessing some antimicrobial activity [19–21]. To 
improve the physical and biological properties, as well as widen the range of potential applications, 
versatile chitosan derivatives have been synthesised [22]. Amphiphilic derivatives are especially 
interesting, due to the presence of a hydrophobic molecules in the chitosan structure, which can 
modify the rheological behaviour, resulting in self-assembly ability [23–25]. There are also studies that 
show improvements in blood compatibility and antimicrobial activity [26]. Our prior work has 
explored the modification of chitosan with fatty acids (linoleic and dilinoleic acid) and examined the 
antimicrobial properties of these new materials [27,28]. Catheter related infections remain a serious 
problem in both intravascular applications[29] (indwelling catheters, in particular), as well as in 
urinary applications.[30] As a result, the combination of blood compatibility and antimicrobial 
properties, if combined with good lubricity, would make these chitosan derivatives of great interest as 
coatings for catheter applications.  
 
The aim of our present work was to investigate the friction behaviour of the chitosan fatty acid 
derivative coatings, benchmarking them against commercially available coatings, in order to assess 
their potential for catheter coating applications. For this purpose an in vitro biotribology test system 
was developed. It was our goal to emulate the in vivo friction conditions of a typical endovascular 
catheterization procedure, whilst avoiding many of the experimental and regulatory issues associated 
with ex vivo and in vivo testing. The test system, which was necessarily limited in its ability to simulate 
the real conditions, consisted of synthetic materials instead of living tissues or blood to minimize 
variability resulting from the lack of reproducibility of living tissues and also to facilitate comparisons 
between the coatings.   
 
2. Experimental  
 
2.1 Tribological system 
An in vitro tribological system was developed in order to compare the friction behaviour of hydrophilic 
coatings intended to be used on the outside of cardiovascular catheters. As far as possible, the 
individual elements of the system were matched to reflect the conditions of the catheterization 
process. 
 
2.1.1 Tribological testing conditions 
Reciprocating sliding friction tests were carried out using a CETR (Brüker) UMT Multi-Specimen Test 
System. The test set-up is shown schematically in Fig.1. In line with the application, the value and 
stability of the friction coefficient was investigated for a total sliding distance of 0.9m, this being a 
distance considered to be typical of a routine endovascular catheterisation procedure. Because it is 
the friction behaviour rather than the wear behaviour that determines the performance in this 
application, the actual wear of the coatings in terms of volumetric wear loss was not investigated 
here. The coatings to be tested were deposited on injection-moulded spherical poly(ether-b-
amide)(PA) polymer probes (representing the catheter material) with a diameter of 3.95 mm and 
rubbed against flat pieces of soft poly(vinyl alcohol)(PVA) hydrogel which represented the blood 
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vessel. During the test, the probes were partially immersed to a depth of approximately 3mm in a 
glycerol-water mixture representing human blood. A specially-designed holder enabled the wet 
hydrogel to be fixed in place during the test, see Fig. 2. All friction tests were carried out at a load 0.1 
N, velocity 0.5 mm/s and stroke 10 mm at room temperature and each test was repeated at least five 
times using fresh materials and coatings for each test to obtain the average and standard deviation 
values shown in the results section. Estimates of the contact radius (r) of the circular contact area and 
of the mean contact pressure (Pm) were made using a Hertzian contact model (see below) where R is 
the radius of the spherical probe, N is the normal force and E’ is the effective modulus of elasticity: 
 
     (1) 
 
    (2) 
 
The effective elastic modulus is given by: 
 
     (3) 
 
Where EP, EH, ʋP and ʋH are the elastic moduli and Poisson constants of the probe and hydrogel 
respectively. 
 
Manufacturer’s data (Arkema Group) was used for the elastic modulus of the PA33 material: 14.6 
MPa. For the harder PA69 material the manufacturer’s data (Arkema Group) on the flexural modulus 
was used as a first approximation of the elastic modulus: 510 MPa (ISO 178 test method). This is a 
reasonable assumption in view of the small expected deformation of the polymer in this case. For the 
PVA hydrogel the value of the compressive modulus at 0.1N force was used as a first approximation of 
the elastic modulus: 16.8 kPa. A value of 0.4 was taken as the Poisson constant for the probe polymers 
PA33 and PA69 and a value of 0.44 was used for the PVA hydrogel[31]. Using the above equations and 










Fig. 2 Hydrogel fixing tool used in the tribological tests. 
 
2.1.2 Blood Vessel analogue (PVA Hydrogel) 
A key element of the tribological system developed here was the selection of contact partner of the 
coatings intended to simulate the blood vessel lumen. It is apparent from previous research into 
biomechanical modelling and the development of synthetic blood vessels for clinicians’ training 
devices that PVA hydrogel can be used to simulate the interior of blood vessels [32–34]. In addition to 
having similar  mechanical properties, PVA hydrogels have a high water content resulting in a low 
surface friction resistance and low interfacial energy with water or biological fluids [35], thus these 
materials canmimic human soft tissues. 
An important advantage of PVA is the possibility to plan/design its properties by suitable selection of 
the ratio of hydrogel components, for example by changing the PVA and/or crosslinking agent 
concentration [36–38].  In this study, based on the work of Watler et al. [36], 10 wt% of PVA was 
chemically cross-linked using glutaraldehyde in the presence of magnesium chloride. The reaction of 
glutaraldehyde with hydroxyl groups of PVA results in a stable chemical network of acetal bridges. 
In terms of simulation of the blood vessel for tribological testing the crucial feature was the low 
friction and reproducible friction behaviour of the PVA surface. 
The hydrogel was produced from PVA powder, trade name Elvanol 90-50 from DuPont (degree of 
hydrolysis and molecular masses: 99 to 99.8% and Mn = 29700 g/mol, Mw = 55800 g/mol). 
Glutaraldehyde solution (GA) and magnesium chloride were used for the chemical crosslinking of the 
PVA. To produce the PVA hydrogel, PVA powder (10% wt.) was fully dissolved in distilled water for 48 
hours at 70oC. The PVA solution was subsequently cooled and MgCl2 (2% wt.) and GA (4% wt.) were 
added. This mixture was then vigorously mixed for 5 min and cast into plastic petri-dishes. Drying was 
carried out very slowly (48 h) to avoid the formation of surface irregularities as a result of shrinkage. 
Subsequently, hydrogel cross-linking was carried out for 2 h at 70oC. Once hydrated the water content 
of the final material was 90%.  
 
2.1.3 Blood analogue (Glycerol water mixture) 
According to the literature, a common substance that has been used as a human blood analogue is a 
glycerol solution [39–41] and it was chosen as the blood analogue for the tribological system reported 
here. To obtain a fluid with room-temperature viscosity within the range of human blood viscosity at 
body temperature (around 3-4 × 10−3 Pa·s [42,43]), a 46% weight ratio of glycerol to water was used. 
 
2.1.4 Polymeric material used to represent the catheter 
Polymeric probes were made by injection moulding a poly(ether-b-amide) (PA, trade name Pebax®), a 
commonly used polymer in catheters. Typically, guide catheters are constructed from several 
hardnesses of polymers, see Fig. 3. This is to provide flexibility at the distal end of the catheter to 
allow easier negotiation of bends. The catheter tip is typically the softest material so that it is 
relatively atraumatic. The material further away from the tip is relatively stiff in order that the 
catheter has sufficient back-up. For this reason, two PAs with different hardness, 33 Shore D (Pebax® 
3533) and 69 Shore D (Pebax® 7233) were tested (and marked in this work as PA33, and PA69, 
respectively), to reflect the different degrees of flexibility in various parts of the catheter. To make the 
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tested probes resemble the catheter material more closely, 3% blue dye (MEVOPUR® AH5M176002 
medical colour master batch from Clariant International Ltd., Switzerland) was added to the polymer 
granulate during injection moulding of the probes, see Fig 4. 
 
 
Fig. 3. The different degrees of flexibility in various parts of the catheters. 
 
 Fig. 4 Poly(ether-b-amide)(PA) probes, injection moulded. Left: 33 ShD, 





2.1.5.1 Chitosan Derivative Coatings 
Coatings of chitosan derivatives were obtained by chemical modification of chitosan (CH) (Chitosan 
low molecular weight, Sigma-Aldrich) with fatty acids. Linoleic acid (LA) (Sigma-Aldrich) and dilinoleic 
acid (DLA) (Croda, The Netherlands), which are natural hydrophobic compounds, were intended to 
improve the physical and biological properties of chitosan. Details of this chemical alteration and 
characterization of antibacterial properties of these hydrophobic chitosan derivatives, CHLA and 
CHDLA, are described elsewhere [27,28].  The chemical structures of the chitosan derivatives tested 
are shown in Fig. 5. 
 
 





2.1.5.2 Commercial Coatings 
As reference materials, three different commercial coatings were investigated, all of which were 
hydrophilic and medical grade, see table 1. The first coating (C1) was a non-toxic thermoplastic 
hydrophilic copolymer based on vinylpyrrolidone and acrylate block, commonly used as a coating for 
medical devices such as guide wires and catheters. Coatings C2 and C3 were ether-based hydrophilic 
urethanes designed for use as coatings for a wide range of medical devices. According to data from 
the supplier, C2 has 50% water absorption and 50% linear expansion and C3 has 90% water absorption 
and 100% linear expansion. 
 
Table 1. Summary of coating materials. 
Designation Type of polymer Comments 
CH Polysaccharide chitosan 
CHLA Polysaccharide/fatty acid chitosan/linoleic acid 
CHDLA Polysaccharide/fatty acid chitosan/dilinoleic acid 
C1 Copolymer vinylpyrrolidone and acrylate copolymer 
C2 Ether-based hydrophilic urethane 50% water absorption, 50% linear expansion 
C3 Ether-based hydrophilic urethane 90% water absorption, 100% linear expansion 
 
2.1.4.3  Coatings preparation 
Coatings from chitosan and chitosan derivatives were prepared by dip-coating on activated PA probes. 
The activation of the surfaces was carried out by immersing the probes in 30% hydrogen peroxide for 
30 minutes at 70oC and then in EDC/alcohol solution for 30 min at room temperature. The catalyst 
solution – EDC/alcohol solution was obtained by dissolving 1g of 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC) in a mixture of ethanol (10 ml) and isopropanol (40 ml). Activated PA probes were 
dipped into a chitosan or chitosan derivatives solution (2% wt. in 1/1 mixture of 1% acetic 
acid/isopropanol (v/v)), held for 2 min and then dried in air. 
The commercial coatings were prepared according to the manufacturer's instructions, also using the 
dip-coating technique. The polymer probes were dipped in 5% (wt.) coating solutions in 1-methyl-2-
pyrrolidone (NMP) for 2 min. The probes were then dried for 2.5 h at 55oC. 
 
2.2 Contact angle measurement 
Contact angle measurements were carried out on the coatings because this parameter is an indicator 
of the surface properties (hydrophilic or hydrophobic), which are important for the lubricity. The 
water contact angle was measured by sessile drop shape analysis according to European Standard EN 
828 using a goniometer Krüss DSA 100 Drop Shape Analyzer equipped with a camera and recording 
system. Contact angle test samples were prepared by dip coating PA disks, in the same way as for the 
tribological test probes. A 2-µL distilled water drop was applied on different areas of the sample. The 
contact angle was measured every second for a period of 60 seconds. Contact angle values for 1, 15, 
30, and 60 seconds were selected as measurement points. The average angle was calculated from 5 
measurements. Additional measurements were performed with coated PA disks immersed in blood 
analogue for 30 min, followed by blotting to remove surface moisture. 
 
3. Results and discussion 
 
3.1 Friction behaviour of uncoated polymer 
Fig. 6 shows the average change in coefficient of friction (CoF) with time (at a sliding velocity 0.5 
mm/s) for the uncoated polyamide probes, PA33 and PA69. The error bars in this figure represent one 
standard deviation (taken from five repeat tests). The CoF values for both materials begin at around 
0.2. However, whilst the CoF of the harder PA69 material remained almost constant for the duration 
of the test, the CoF of the softer PA33 material gradually increased with sliding distance. The reason 
for this increase is unclear; however, it may be attributed to significant plastic deformation of the 
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softer material occurring during the test, resulting in a gradually increasing contact surface area in 
time and hence greater adhesion and/or deformation friction. 
 
 
Fig. 6 Measured average coefficient of friction for uncoated polyamides PA33 and PA69. The error 
bars represent one standard deviation. 
 
3.2 Friction behaviour of coatings 
Fig. 7 shows a comparison of the average friction behaviour of the uncoated polyamides (PA33, PA69) 
and the same material coated by chitosan (CH) and the chitosan derivatives (CHLA and CHDLA) (panels 









Fig. 7 Average coefficient of friction as a function of time for PA uncoated and coated by chitosan and 
its derivatives or commercial coatings. Panels A and B represent PA33. Panels C and D represent PA69. 
 
With all the coatings tested, the friction coefficient was initially relatively high but decreased during a 
short running-in period to a lower, stable value or remained stable for the remaining duration of the 
test. An increase in the friction during this period, becoming closer to the value for uncoated material, 
would have been an indication of coating wear and insufficient lifetime. No such increase in the 
friction coefficient was observed during the test period for any of the coatings tested, indicating that 
all of the coatings had sufficient lifetime as regards wear performance.   
 
It is clear that all of chitosan coatings show lower CoF than the uncoated material, demonstrating the 
lubricious properties of chitosan itself. It is interesting to note that there are very few references in 
the literature to research on the friction reducing effect of chitosan [44,45]. The current work is the 
first in which chitosan and chitosan derivatives have been applied as lubricious coatings. After 
running-in, both of the chitosan derivatives tested showed approximately the same CoF behaviour 
with the harder (PA69) polymer material as substrate, indicating that the type of fatty acid used in the 
chitosan derivative did not have a significant influence. 
 
The chitosan derivative coatings were also compared with three hydrophilic commercial coatings, see 
Table 1.  Fig 8A and B show the average CoF values for the uncoated and coated soft PA33 (A) and 
hard PA69 (B) materials, respectively. For each test, the CoF values shown in Fig. 8 are averages from 
the test period between 800 and 1700s sliding time, when the CoF had reached a relatively stable and 





Fig. 8 Average coefficient of friction results for all tests using (A) softer PA33 polymer and (B) harder 
PA69 polymer substrates for the coatings. The errors bars indicate one standard deviation derived 
from at least five separate tests, each using fresh materials and coatings.   
 
Fig. 8 shows that all of the coatings tested decreased the coefficient of friction compared to the 
uncoated polymer but that there are differences between the results for the softer PA33 and harder 
PA69 substrates. It has already been mentioned that, in general, the higher observed friction values 
for the PA33 material may be attributed to greater viscoelastic deformation of this softer material, 
leading to a greater contact area and hence greater adhesion and/or deformation friction. In addition, 
the Pebax substrate used is a block copolymer, where the phase structure and bulk mechanical 
properties, such as hardness, depend on the relative amounts of its “hard” and “soft” constituents 
(blocks). The two substrate polymers have different block compositions, with PA33 having more 
hydrophilic ether “soft” blocks. This may affect the interaction between the amphiphilic coating 
molecules and the substrate. This effect may play a greater role in the case LA-modified chitosan, due 
to LA having a lower molecular weight and being more able to reorganize. We hypothesized that these 
interactions would have an effect on the contact angle and water absorption properties of the applied 
coatings. This in turn, would then be expected to influence the friction behaviour of the coatings. 
Importantly, in the case of the coated PA69 polymer, which is representative of the bulk of the length 
of a guide catheter, it is clear that both of the chitosan derivatives coatings (CHLA and CHDLA) 
reduced the friction to levels similar to those of the commercially-available coatings C1, C2 and C3. 
 
3.4 Surface wettability 
The wettability of biomaterials is very important for their biocompatibility, especially 
hemocompatibility [46] and this also can influence the friction behaviour [47]. In general, hydrophilic 
surfaces provide good lubricity while surface hydrophobicity can lead to thrombogenesis arising from 
preferred fibrinogen adsorption activating adhesion of platelets and clotting [48]. 
In order to explain the time course of friction behaviour, the hydrophilicity of the chitosan coatings 
was characterized by measurement of the water contact angle every second for a period of 60 
seconds. A typical result is shown in Fig. 9 for the CHDLA coating after 60s. 
 
 





Fig 10. Time course of contact angle measurements for CHLA (a) and CHDLA (b) coatings on PA. 
 
The results are presented in Figure 10, which shows averages from five separate measurements at 
each time point. By comparison, for all contact times up to 60s, the two uncoated polyamides 
exhibited angles of 90° (PA33) and 101° (PA69), respectively, typical for hydrophobic surfaces, while 
unmodified chitosan (CH) exhibited contact angle of 34°, indicating its hydrophilic character. 
Modification of the chitosan by the hydrophobic fatty acid compounds (monocarboxylic LA and 
dicarboxylic DLA) results in an increase of the contact angle compared to CH. Overall, CHLA has a 
lower contact angle (about 50-60° after 15 s) than CHDLA (about 75-80° after 15 s). Additionally, we 
observe a difference in behaviour between the two coatings on the different substrates. On PA33, 
CHLA has a higher contact angle than on PA69 (Fig. 10a), while the opposite is true for CHDLA (Fig. 
10b). These differences may relate to structural differences between the derivatives relative to the 
substrate. PA33 has more hydrophilic ether “soft” segments, which may favor greater interaction with 
the hydrophilic chitosan chains while the coating forms, as compared to PA69. Thus, for the case of 
CHLA, having shorter pendant aliphatic chain, which is able to reorganize more readily, the outer 
surface of the coating will tend to have more LA groups, resulting in a higher contact angle, as 
compared to CHLA on PA69. PA69, which has less ether blocks, will tend allow for more chitosan 
chains to be exposed on the surface, compared to PA33. In the case of CHDLA, the DLA fatty acid tail is 
terminated with an additional carboxylic (–COOH) group (see Fig. 5) and this may favour interactions 
with the ether blocks of PA33. Additionally, it is possible that via this second carboxylic group, some 
DLA may react two different chitosan molecules, acting as a crosslinker, reducing the polymer chain 
mobility, but potentially increasing the surface energy. On PA33 (Fig. 10b), this may expose more 
chitosan on the surface, resulting in lower contact angle, as compared to PA69. 
 
Upon exposure to aqueous environment, the surface molecules of the coatings will rearrange in order 
to minimize interface energy, exposing more hydrophilic chitosan over time. This effect will result in 
the reduction of contact angle, as observed for both coating materials (Fig. 10). Such a rearrangement 
could lead to alignment of the molecules in the sliding direction and result in a decreased friction 
coefficient. However, the difference in time course between the two coatings is likely due to the fact 
that DLA will tend to hinder rearrangement.  
 
Additionally, during the friction experiments, as shown in Figure 2, the probe was partially immersed 
in the glycerol-water mixture to a (consistent) depth of approximately 3mm. A change in contact angle 
between the liquid and the coating on the probe will also result in a change in surface tension at 
meniscus formed between the fluid and the probe. This change in normal force on the probe is not 
taken into account in the calculation of the friction coefficient and may result in imprecision. This 
force may also further encourage a boundary lubrication condition. Further studies will be needed to 
address the mechanism of time-dependent reduction of CoF and contact angle for the chitosan-fatty 
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acid coatings[49], including careful measurement of the forces acting vertically on the coated probes 
as they approach and become immersed in the fluid before starting the friction test. 
 
However, after 30 min exposure to the aqueous solution, both coatings exhibit zero contact angles, 
indicating an equilibrium condition of complete saturation with water, potentially accounting for 
similar final CoF by the formation of a lubrication layer. 
 
4. Conclusions 
Our work here presents the development of an in vitro tribological system for testing catheter 
coatings, intended to represent, to a limited extent, the in vivo friction conditions of a typical 
endovascular catheterization procedure. Using the developed tribological system, we tested the 
friction behavior of novel modified chitosan coatings and compared them to several commercially 
available coatings. To our knowledge, this is the first time such tests have been performed. Our results 
indicate that chitosan and chitosan modified with linoleic or dilinoleic acid acts as a lubricious coating, 
markedly reducing the coefficient of friction, as compared to neat polyamide substrate. In fact, the 
chitosan-fatty acid coatings were comparable to hydrogel commercial coatings in terms of the 
coefficient of friction, while providing the advantages of being biodegradable and antimicrobial. Our 
results highlight the potential of these novel coatings for both intravascular, as well as urinary, 
catheter applications, where lubricious coatings combined with antimicrobial activity in particular 
would be highly desired. 
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